Welcome to our dedicated page for TENET HEALTHCARE SEC filings (Ticker: THC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TENET HEALTHCARE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TENET HEALTHCARE's regulatory disclosures and financial reporting.
Tenet Healthcare Corp (THC) is named as the issuer in a notice that Saumya S. Sutaria intends to sell common stock under Rule 144. The filing indicates a planned sale of 50,000 common shares of Tenet Healthcare through Fidelity Brokerage Services LLC on the NYSE around 08/25/2026. The shares to be sold are linked to restricted stock vesting awards received from the issuer as compensation, including 47,162 shares vesting on 02/23/2025 and 2,838 shares vesting on 03/01/2024. The notice also reports a prior sale during the past three months of 50,000 common shares on 08/24/2026.
TENET HEALTHCARE CORP (THC) is the issuer of common stock that Cecil D. Haney, a director, has notified an intent to sell under Rule 144. The notice covers 1,300 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $361,439.00 and referencing 80,519,000 shares outstanding and an approximate sale date of 08/24/2026.
The shares to be sold were acquired from the issuer as compensation via restricted stock vesting events of 322 shares on 05/07/2024 and 978 shares on 05/23/2025.
TENET HEALTHCARE CORP (THC) received a notice under Rule 144 for a proposed resale of its common stock for the account of Saumya S. Sutaria through Fidelity Brokerage Services LLC. The notice covers up to 50,000 shares of common stock with an aggregate market value of $13,935,240.26, with an approximate sale date of August 24, 2026. Shares of common stock outstanding were 80,519,000 at the time referenced, which is a baseline figure, not the amount being sold. The securities to be sold were acquired as compensation through restricted stock vesting on three dates in early 2025.
T. Rowe Price Associates, Inc. reported beneficial ownership of 7,954,926 shares of Tenet Healthcare Corp common stock, representing 9.2% of the class. The firm reported sole voting power over 7,857,098 shares and sole dispositive power over 7,954,926 shares, with no shared voting or dispositive power.
T. Rowe Price Associates stated that this filing should not be construed as an admission that it is the beneficial owner of these securities, and such beneficial ownership is expressly denied.
Tenet Healthcare Corp director Tammy Romo reported two open-market sales of Common Stock. On 2026-08-07, she sold 2,500 shares at $260.83 per share, and on 2026-08-06 she sold 4,922 shares at $264.15 per share, totaling 7,422 shares sold. Both positions were reported as direct ownership; post-transaction holdings were not stated.
Tenet Healthcare Corp director Roy Blunt reported selling 600 shares of Common Stock on 2026-08-05 at a weighted average price of $262.68 per share, executed in multiple trades between $262.52 and $262.70. After this sale, he directly holds 4,589 shares.
Tammy Romo filed to sell 2,500 shares of common stock through Fidelity Brokerage Services LLC on August 7, 2026 under Rule 144. The shares, with an aggregate market value of $652,062.50, were originally acquired via restricted stock vesting as compensation on May 8, 2018. Over the prior three months, Romo sold 4,922 shares for total proceeds of $1,300,146.30.
THC reports a planned sale of 4,922 shares of common stock through Fidelity Brokerage Services LLC on or after August 6, 2026 on the NYSE. The shares have an aggregate market value of $1,300,146.30, while 80,519,000 shares were outstanding. The stock to be sold comes from restricted stock vesting awards of 3,836 shares on May 9, 2025 and 1,086 shares on May 23, 2025.
FMR LLC and Abigail P. Johnson report updated beneficial ownership of Tenet Healthcare Corp common stock on a Schedule 13G/A. FMR LLC reports beneficial ownership of 3,994,545.39 shares, representing 4.6% of the common stock outstanding, with sole dispositive power over this entire amount and sole voting power over 3,985,108.16 shares.
The filing states that this represents ownership of 5 percent or less of the class. One or more other persons have rights to receive dividends or sale proceeds from these securities, but no such person holds more than five percent of Tenet Healthcare’s total outstanding common stock. Subsidiary-level details are provided in an attached Exhibit 99.